Long-term evaluation of analytical methods used in sirolimus therapeutic drug monitoring

Proficiency Testing/External Quality Assessment: Current Challenges and Future Directions

(2011) W. G. Miller et al.   CLINICAL CHEMISTRY

Evaluation of the Abbott ARCHITECT i2000 Sirolimus Assay and Comparison With the Abbott IMx Sirolimus Assay and an Established Liquid Chromatography–Tandem Mass Spectrometry Method

(2011) Kamisha L Johnson-Davis et al.   THERAPEUTIC DRUG MONITORING

Evaluation of two sirolimus assays using the ARCHITECT-i1000® CMIA or RxL® ACMIA methods in comparison with the IMx® MEIA method

(2010) Caroline Courtais et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer

(2009) Rainer W. Schmid et al.   CLINICAL BIOCHEMISTRY

The Challenge of Achieving Target Drug Concentrations in Clinical Trials: Experience From the Symphony Study

(2009) Henrik Ekberg et al.   TRANSPLANTATION

Impact of Variability of Sirolimus Trough Level on Chronic Allograft Nephropathy

(2008) M.J. Wu et al.   TRANSPLANTATION PROCEEDINGS